Tender detail
Biologic medicine rebate agreements 2026 – Lot 12: epoetin alfa and epoetin zeta
Summary
The Techniker Krankenkasse (TK) is seeking rebate agreements for epoetin alfa and epoetin zeta through an open-house procedure with uniform contract terms and no individual negotiations or exclusivity. The agreements may run for up to 24 months from 1 July 2026 and end no later than 30 June 2028.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.